Business Context and Reporting Period
Company: iRhythm Technologies, Inc. (IRTC)
Filing Type: Form 8-K (Current Report)
Date: January 13, 2025
Context: The filing discloses a press release issued in connection with the J.P. Morgan 43rd Annual Healthcare Conference. The release contains preliminary fourth quarter 2024 highlights, business updates, and updated financial outlooks for fiscal years 2024 and 2025.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not detailed within the body of this Form 8-K.
Material Changes
The filing indicates the announcement of preliminary fourth quarter 2024 highlights and updated financial outlooks. Specific quantitative changes versus prior periods are not disclosed in this text.
Guidance, Outlook, and Risks
- Guidance: The company provided updated financial outlooks for fiscal year 2024 and fiscal year 2025.
- Forward-Looking Statements: The filing contains statements regarding market opportunity, penetration, productivity, quality improvements, and growth expectations.
- Risks: Management notes that actual results may differ materially due to risks and uncertainties described in the "Risk Factors" section of recent Form 10-K and Form 10-Q filings.
- Disclaimer: iRhythm disclaims any obligation to update forward-looking statements.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 2024 revenue and profit figures.
- Verify the updated full-year 2024 and full-year 2025 financial guidance ranges.
- Consult the most recent Form 10-K and 10-Q for detailed risk factors referenced in the forward-looking statements.
- Confirm the timing and content of the J.P. Morgan Healthcare Conference remarks referenced in the filing.